查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917889

安宁疗护市场—2026-2031年预测

Palliative Care Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2025 年，安宁疗护市场规模将达到 154.56 亿美元，到 2031 年将达到 235.81 亿美元，复合年增长率为 7.29%。

安宁疗护市场是更广泛的医疗保健系统中一个重要且不断增长的组成部分，其重点在于改善面临严重、复杂且往往危及生命的疾病的患者的生活品质。与安宁疗护不同，安宁疗护适用于严重的任何阶段，并且可以与治癒性治疗同时进行。其核心使命是透过对疼痛、呼吸困难和噁心等生理症状进行专业管理来减轻患者的痛苦，同时为患者及其家属提供心理社会和精神支持。推动市场成长的因素包括人口趋势、医疗保健服务模式转移，以及安宁疗护原则日益融入标准医疗实践。

关键成长要素包括全球严重慢性疾病盛行率的上升和社会老化。随着人口寿命的延长，诸如晚期癌症、心臟衰竭、慢性阻塞性肺病和神经退化性疾病等复杂进行性性疾病的负担显着增加。这些疾病通常伴随严重的症状负担和功能衰退，因此迫切需要安宁疗护提供的专业且全面的支持。这种人口和流行病学现实造就了庞大且不断增长的安宁疗护受益患者群体，从而确保了对安宁疗护服务的持续需求。

同时，病人、家属和医护人员对安宁疗护的认识和接受度不断提高，也是推动安宁疗护发展的重要因素。倡导团体、专业协会和医疗机构的教育努力逐渐转变了人们的观念，使安宁疗护不再仅仅被视为临终关怀，而是成为高品质、全面性严重疾病治疗的重要组成部分。人们越来越认识到，早期引入安宁疗护可以改善患者预后，提高患者满意度，在某些情况下甚至可以延长存活期。这种文化转变正在消除以往对安宁疗护的偏见，鼓励更早转诊，并就治疗目标展开更公开的讨论。

塑造市场格局的关键趋势之一是将安宁疗护积极融入主流医疗保健系统和政策。这不再局限于独立的安宁疗护项目，而是将安宁疗护理念和专业团队融入肿瘤科、心臟科和神经科等医疗专科。医疗机构正在发展住院会诊服务、专科门诊，并在责任医疗组织（ACO）内建立嵌入式安宁疗护模式。推动这一整合的依据是，有证据表明安宁疗护有助于降低医院再入院率，减少临终阶段不必要的过度治疗，并使医疗服务与病人的价值观相契合——这些都是基于价值的医疗报销模式的关键指标。

为满足病患意愿和提高医疗效率，居家安宁疗护服务的需求显着增长。大多数患者都希望尽可能长时间地留在自己家中。居家模式直接为患者提供多学科护理，包括护理、医生监督、社工服务和心理治疗，在舒适宜人的环境中管理复杂的症状并提供支持。此模式已展现出显着减少急诊就诊和住院次数的潜力，在尊重患者自主权的同时，也为支付方提供了一种经济高效的选择。居家医疗基础设施的扩展和远端医疗能力的提升，正进一步推动这项转变。

从地理上看，欧洲通常被认为是安宁疗护发展和整合领域的领导者，这得益于其健全的政策框架、政府主导的倡议以及较高的公众意识。许多欧洲国家製定了国家安宁疗护发展策略，并推动将其纳入全民健康覆盖（UHC）。这项既定基础造就了比其他许多地区更成熟的市场和更广泛的服务覆盖率。

此服务模式具有跨学科性质，需要医生、高级执业医师、护士、社工、牧师和治疗师之间的协作。服务在多种场所提供：住院会诊团队、专门的住院病房、门诊诊所、家庭护理项目以及长期护理机构。多样化的服务场所确保了护理的连续性，并能够适应不断变化的患者需求和病情严重程度。

竞争格局呈现出多元化的服务提供者组成，包括专业的安宁疗护机构、已拓展至安宁疗护领域的大型居家医疗和临终关怀机构、医院和医疗系统旗下的项目，以及非营利组织。成功的关键在于：透过改善患者报告的疗效和降低医疗资源利用率来展现明确的临床价值；透过与支付方和医疗系统签订合约来获得永续的报酬；以及在竞争激烈的领域中吸引和留住专业的临床人才。

总之，安宁疗护市场正从一项辅助服务发展成为现代医疗保健中应对严重疾病的重要组成部分。其成长得益于结构性因素：人口趋势和慢性病管理日益复杂化。未来，持续向基于价值的支付模式转型、居家服务的成功推广、在非肿瘤诊断领域的进一步渗透，以及透过培训和教育不断提升临床能力，都将推动安宁疗护市场的发展。这一市场轨迹反映了医疗服务理念的根本性转变，即优先考虑患者的生活品质、目标以及在整个严重病程中提供全面的支持。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在动态环境中做出策略决策，并开拓新的商机和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

您打算如何使用这份报告？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

第五章 按类型分類的安宁疗护市场

  • 介绍
  • 居家临终关怀
  • 护理中心的安宁疗护
  • 医院的安宁疗护
  • 住院安宁疗护

第六章 按应用领域分類的安宁疗护市场

  • 介绍
  • 癌症
  • 心血管疾病
  • 神经系统疾病
  • 慢性肾臟病
  • 呼吸系统疾病
  • 其他的

第七章 按年龄组别分類的安宁疗护市场

  • 介绍
  • 孩子们
  • 成人
  • 老年人

第八章 各地区的安宁疗护市场

  • 介绍
  • 北美洲
    • 按类型
    • 透过使用
    • 按年龄组
    • 按国家/地区
      • 我们
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按类型
    • 透过使用
    • 按年龄组
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按类型
    • 透过使用
    • 按年龄组
    • 按国家/地区
      • 德国
      • 法国
      • 英国
      • 西班牙
      • 义大利
      • 其他的
  • 中东和非洲
    • 按类型
    • 透过使用
    • 按年龄组
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按类型
    • 透过使用
    • 按年龄组
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 印尼
      • 泰国
      • 台湾
      • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Chemed Corporation
  • Humana Inc.
  • Gentiva
  • Amedisys, Inc.
  • AccentCare Inc.
  • Crossroads Hospice & Palliative Care
  • Caris Healthcare, LP
  • Compassus
  • Sunrise Senior Living（Revera）
  • Home Instead, Inc.（Honor Technology, Inc）

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615954

Palliative Care Market is expected to grow at a 7.29% CAGR, increasing to USD 23.581 billion in 2031 from USD 15.456 billion in 2025.

The palliative care market is a critical and expanding segment within the broader healthcare continuum, focused on improving the quality of life for patients facing serious, complex, and often life-limiting illnesses. Distinct from hospice care, palliative medicine is appropriate at any stage of a serious illness and can be provided alongside curative treatment. Its core mission is the relief of suffering through expert management of physical symptoms-such as pain, dyspnea, and nausea-coupled with the provision of psychosocial and spiritual support for both patients and their families. The market's growth is driven by the convergence of demographic trends, a shifting paradigm in healthcare delivery towards value and patient-centeredness, and increasing integration of palliative principles into standard medical practice.

A primary growth catalyst is the rising global prevalence of serious chronic illnesses and an aging population. As populations live longer, the burden of complex, progressive conditions like advanced cancer, heart failure, chronic obstructive pulmonary disease, and neurodegenerative diseases increases substantially. These conditions often involve significant symptom burdens and functional decline, creating a profound need for the specialized, holistic support that palliative care provides. This demographic and epidemiological reality establishes a large and growing patient population that benefits from palliative intervention, ensuring sustained demand for services.

Concurrently, the increasing awareness and acceptance of palliative care among patients, families, and healthcare professionals is a significant driver. Educational initiatives by advocacy organizations, professional societies, and healthcare institutions have progressively shifted perceptions, moving palliative care from a modality associated solely with the end of life to a recognized component of high-quality, comprehensive care for serious illness. There is greater understanding that early integration of palliative care can improve patient outcomes, enhance satisfaction, and in some cases, even extend survival. This cultural shift is reducing historical stigma and is encouraging earlier referrals and more open discussions about goals of care.

A major trend shaping the market is the active integration of palliative care into mainstream healthcare systems and policies. This is moving beyond standalone programs toward embedding palliative care principles and specialist teams within oncology, cardiology, neurology, and other specialty departments. Healthcare institutions are establishing inpatient consultation services, dedicated outpatient clinics, and embedded models within accountable care organizations. This integration is driven by evidence demonstrating that palliative care can reduce hospital readmissions, decrease unnecessary and aggressive care at the end of life, and improve care alignment with patient values-key metrics in value-based reimbursement models.

Aligned with patient preference and healthcare efficiency, there is a pronounced increase in demand for home-based palliative care services. Most patients express a desire to remain at home for as long as possible. Home-based models deliver interdisciplinary care-including nursing, physician oversight, social work, and therapy-directly to the patient, managing complex symptoms and providing support in a preferred, comfortable setting. This model has demonstrated significant potential to reduce emergency department visits and hospitalizations, making it economically favorable for payers while honoring patient autonomy. The growth of home health infrastructure and telehealth capabilities is further enabling this shift.

Geographically, Europe is often regarded as a leader in the development and integration of palliative care, supported by strong policy frameworks, government-led initiatives, and a high level of public awareness. Many European countries have national strategies for palliative care development and have worked to ensure its inclusion in universal health coverage. This established foundation fosters a more mature market with broader access compared to many other regions.

The service delivery model is inherently interdisciplinary, requiring collaboration between physicians, advanced practice providers, nurses, social workers, chaplains, and therapists. Services are delivered across multiple settings: inpatient hospital consultation teams, dedicated inpatient units, outpatient clinics, home-based programs, and within long-term care facilities. The variety of settings allows for a continuum of care that can adapt to changing patient needs and acuity levels.

The competitive landscape includes a diverse mix of providers: specialized palliative care organizations, large home health and hospice agencies that have expanded into palliative care, hospital and health system-based programs, and nonprofit entities. Success depends on the ability to demonstrate clear clinical value through improved patient-reported outcomes and reduced healthcare utilization, secure sustainable reimbursement through contracts with payers and health systems, and recruit and retain specialized clinical talent in a competitive field.

In conclusion, the palliative care market is evolving from a complementary service into an essential component of modern healthcare for serious illness. Its growth is structurally supported by demographic trends and the increasing complexity of chronic disease management. Future expansion will be shaped by the continued movement towards payment models that reward its value, successful scaling of home-based delivery, further penetration into non-cancer diagnoses, and ongoing efforts to build clinical capacity through training and education. The market's trajectory reflects a fundamental reorientation towards care that prioritizes quality of life, patient goals, and holistic support throughout the course of a serious illness.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Palliative Care Market Segmentation

  • By Type
  • Palliative Care At Homes
  • Palliative Care in Care Center
  • Palliative Care in Hospitals
  • Inpatient Palliative Care
  • By Application
  • Cancer
  • Cardiovascular Disease
  • Neurological Disorder
  • Chronic Kidney Disease
  • Respiratory Disease
  • Others
  • By Age-Group
  • Pediatric
  • Adult
  • Elderly
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PALLIATIVE CARE MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Palliative Care At Homes
  • 5.3. Palliative Care in Care Center
  • 5.4. Palliative Care in Hospitals
  • 5.5. Inpatient Palliative Care

6. PALLIATIVE CARE MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cancer
  • 6.3. Cardiovascular Disease
  • 6.4. Neurological Disorder
  • 6.5. Chronic Kidney Disease
  • 6.6. Respiratory Disease
  • 6.7. Others

7. PALLIATIVE CARE MARKET BY AGE-GROUP

  • 7.1. Introduction
  • 7.2. Pediatric
  • 7.3. Adult
  • 7.4. Elderly

8. PALLIATIVE CARE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Age-Group
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By Age-Group
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By Age-Group
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By Age-Group
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By Age-Group
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Chemed Corporation
  • 10.2. Humana Inc.
  • 10.3. Gentiva
  • 10.4. Amedisys, Inc.
  • 10.5. AccentCare Inc.
  • 10.6. Crossroads Hospice & Palliative Care
  • 10.7. Caris Healthcare, L.P.
  • 10.8. Compassus
  • 10.9. Sunrise Senior Living (Revera)
  • 10.10. Home Instead, Inc. (Honor Technology, Inc)

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations